Evidence map›Paper›PMID 37201957›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2023

Evaluation of

Kondapa Naidu Bobba, Anil P Bidkar, Niranjan Meher, Cyril Fong, Anju Wadhwa, Suchi Dhrona, Alex Sorlin, Scott Bidlingmaier, Becka Shuere, Jiang He and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 33 citations in OpenAlex.

  1. Quantitative SPECT imaging ofMedical physics · 2026
    Article
  2. ImprovedACS omega · 2026
    Article
  3. Article
  4. Synergistic Treatment of Prostate Cancer and Multiple Myeloma using CD46-Targeted Radioimmunotherapy Antibody-Drug Conjugates.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  5. Article
  6. Stabilities of AcInorganic chemistry · 2026
    Article
  7. PretargetedTheranostics · 2026
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Evaluation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  14. Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  15. Radiotheranostic landscape: A review of clinical and preclinical development.European journal of nuclear medicine and molecular imaging · 2025
    Review
  16. Article
  17. Article
  18. Examination of the PET in vivo generatorEuropean journal of nuclear medicine and molecular imaging · 2024
    Article
  19. Article
  20. Chelation of [Dalton transactions (Cambridge, England : 2003) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Kondapa Naidu BobbaDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Anil P BidkarDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Niranjan MeherDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Cyril FongDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Anju WadhwaDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Suchi DhronaDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Alex SorlinDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Scott BidlingmaierDepartment of Anesthesia, University of California, San Francisco, San Francisco, California.
Becka ShuereDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Jiang HeDepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, Virginia; robert.flavell@ucsf.edu henry.vanbrocklin@ucsf.edu.
David M WilsonDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Bin LiuDepartment of Anesthesia, University of California, San Francisco, San Francisco, California.
Youngho SeoDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Henry F VanBrocklinDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California; robert.flavell@ucsf.edu henry.vanbrocklin@ucsf.edu.
Robert R FlavellDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
University of California, San Francisco · USUCSF Helen Diller Family Comprehensive Cancer Center · USUniversity of Virginia · US

Funding

Novel radioimmunoconjugates for targeted alpha-particle therapy of metastatic prostatic cancerR01CA223767 · NCI · UNIVERSITY OF VIRGINIA · PI HE, JIANG, LIU, BIN · 2018 to 2022
$2.8M
NCI NIH HHS R01 CA223767
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Positron Emission Tomography Computed TomographyProstatic NeoplasmsAnimalsCell Line, TumorHumansLigandsMaleMiceMice, Inbred C57BLPositron-Emission TomographyPrecision MedicineRadiopharmaceuticalsTissue DistributionLigandsRadiopharmaceuticals134Ce225AcPET imagingPSMA-617targeted α-radiotherapyYS5 antibody

Identifiers

PMID37201957
PMCPMC10315697
OpenAlexW4377019870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.